| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO And CFO
1 company
Patel Snehal is a CEO And CFO at Greenwich LifeSciences, Inc.. Recent SEC Form 4 filings include 11 buys and 0 sells.
Estimated insider holdings value: $80.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 31, 2025 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 2,300 | $9.26 | $21,298.00 | - | +226.0% | - | |
| Apr 25, 2025 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 3,600 | $9.88 | $35,568.00 | - | +15.1% | - | |
| Apr 17, 2025 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 5,400 | $8.98 | $48,492.00 | - | +25.0% | - | |
| Apr 7, 2025 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 3,600 | $9.10 | $32,760.00 | - | +5.0% | +134.7% | |
| Apr 4, 2025 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 5,500 | $8.73 | $48,015.00 | - | +13.6% | +149.5% | |
| Jan 10, 2025 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 2,500 | $12.51 | $31,275.00 | - | -24.7% | +104.2% | |
| Jan 7, 2025 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 2,900 | $13.58 | $39,391.00 | - | -30.6% | +80.9% | |
| Jan 3, 2025 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 3,400 | $12.95 | $44,030.00 | - | -28.2% | +51.2% | |
| Jan 2, 2025 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 2,000 | $11.97 | $23,940.00 | - | -20.4% | +65.8% | |
| Dec 31, 2024 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 2,400 | $11.36 | $27,264.00 | - | -15.0% | +87.1% |